Rite Aid Corp

Most Recent

  • uploads///
    Company & Industry Overviews

    Amazon Challenges Walgreens and CVS Health Again

    Amazon (AMZN) recently began letting customers use funds in their special healthcare savings account to pay for purchases of eligible products on its marketplace, the company confirmed to CNBC.

    By Ruchi Gupta
  • uploads///
    Consumer

    How Investors Reacted to Walgreens’s Fourth-Quarter Results

    Walgreens stock has fallen 2.4% YTD (year-to-date). It fell ~10% after Amazon announced the acquisition of Pillpack in June.

    By Sonya Bells
  • uploads///
    Consumer

    Walgreens: Key Revenue Drivers in Fourth Quarter of Fiscal 2018

    Walgreens’s Retail Pharmacy USA division accounted for 76% of fourth-quarter sales and increased 14.4% YoY to $25.5 billion.

    By Sonya Bells
  • uploads///close up _
    Consumer

    Walgreens Stock Rises as RBC Increases Price Target 20%

    RBC Capital Markets raised the price target for Walgreens Boots Alliance (WBA) from $68 to $82 (or ~20%) on Monday, October 8.

    By Sonya Bells
  • uploads///
    Consumer

    Walgreens’s EPS to Rise 11% in Q4 2018

    Wall Street expects a 10.7% year-over-year jump in Walgreens Boots Alliance’s (WBA) EPS to $1.45 during the fourth quarter of fiscal 2018.

    By Sonya Bells
  • uploads///
    Consumer

    Rite Aid Reports in-Line EPS in the Second Quarter

    Rite Aid (RAD) reported a second-quarter adjusted net loss from continuing operations of $7.9 million or $0.01 loss per share.

    By Sonya Bells
  • uploads///
    Consumer

    Rite Aid Finally Posts Top-Line Growth in the Second Quarter

    Rite Aid (RAD) reported results for the second quarter—which ended on September 1—yesterday. The company’s top line from continuing operations improved 1.4 % YoY (year-over-year) to $5.42 billion.

    By Sonya Bells
  • uploads///
    Consumer

    After Two Failed Mergers, Where Does Rite Aid Stand Now?

    Struggling with the company’s financial position, Rite Aid’s management has tried to sell the company’s assets since 2015.

    By Sonya Bells
  • uploads///
    Consumer

    Why Are Rite Aid’s Margins Deteriorating?

    Rite Aid Corporation (RAD) is expected to post an adjusted loss of 1 cent per share when it reports its second-quarter 2019 results on September 27.

    By Sonya Bells
  • uploads///
    Consumer

    Strong Q2 2018 Results Cushion CVS Health’s Falling Share Price

    CVS Health’s (CVS) better-than-expected second-quarter results managed to please investors.

    By Sonya Bells
  • uploads///dead end street sign road traffic
    Consumer

    Rite Aid Terminated Its Merger Agreement with Albertsons

    On August 8, Albertsons and Rite Aid (RAD) announced that they mutually terminated their merger agreement, which was announced in February.

    By Sonya Bells
  • uploads///medications _
    Consumer

    Rite Aid Stock Fell Due to Lower Fiscal 2019 Outlook

    Rite Aid (RAD) stock took a hit on August 6 after management updated the fiscal 2019 profit outlook.

    By Sonya Bells
  • uploads///us pharmacies
    Company & Industry Overviews

    How Pharmacies and Drugstores Are Defending against Amazon

    Amazon’s (AMZN) purchase of PillPack is expected to pose a threat to existing players in the pharmaceutical space.

    By Anne Shields
  • uploads///
    Consumer

    Walgreens Reports 14% Sales Growth in Fiscal Third Quarter

    Walgreens’s fiscal third-quarter top line increased 14% YoY to $34.3 billion. On a constant currency basis, sales rose 11.8% YoY.

    By Sonya Bells
  • uploads///
    Consumer

    Rite Aid’s Fiscal Q1 2019 Beat Drives Its Stock After Hours

    Rite Aid’s (RAD) better-than-expected results drove its stock by 1.5% in the post-trading session on June 27.

    By Sonya Bells
  • uploads///
    Consumer

    Discussing Rite Aid’s Fiscal Q1 2019 Margins

    Rite Aid (RAD) reported adjusted net income from continuing operations of -$11.5 million, or -$0.01 per share, in the fiscal first quarter of 2019.

    By Sonya Bells
  • uploads///
    Consumer

    What Drove Rite Aid’s Fiscal Q1 2019 Sales Down?

    Rite Aid’s Retail Pharmacy segment recorded a 1.9% YoY sales fall during the fiscal first quarter of 2019.

    By Sonya Bells
  • uploads///hypertension _
    Consumer

    Here’s Why Rite Aid Fell 7% Yesterday

    Rite Aid stock tumbled 7% yesterday after the company issued a letter that asked shareholders to vote in favor of the pending merger with Albertsons.

    By Sonya Bells
  • uploads///Picture
    Consumer

    Analysts Aren’t So Sure about Rite Aid Stock

    After a disastrous 2017, Rite Aid stock has managed to stay in the green so far this year.

    By Sonya Bells
  • uploads///
    Consumer

    What’s behind Rite Aid’s Deteriorating Margins?

    Rite Aid has witnessed a continuous deterioration in its profitability over the years.

    By Sonya Bells
  • uploads///
    Consumer

    What Are Rite Aid’s Key Revenue Drivers?

    Rite Aid (RAD) is projected to report a 31.6% YoY (year-over-year) decline in total sales to $5.3 billion.

    By Sonya Bells
  • uploads///first aid _
    Consumer

    What to Expect from Rite Aid’s Q1 2019 Results

    Rite Aid stock has risen a moderate 2.2% this year after falling 76% last year. Wall Street, however, expects some recovery in the stock price this year.

    By Sonya Bells
  • uploads///
    Consumer

    Rite Aid’s Top Line Fell for 4th Straight Quarter in Fiscal 4Q18

    Rite Aid’s (RAD) top line for fiscal 4Q18 fell 8.6% YoY to $5.4 billion, missing the average consensus expectation by $180 million.

    By Sonya Bells
  • uploads///R
    Consumer

    How Wall Street Views Rite Aid Stock ahead of 4Q18 Results

    Rite Aid’s stock has plunged around 18% this year after falling 76% last year.

    By Sonya Bells
  • uploads///grocery store _
    Consumer

    SuperValu Has Decided to Sell Farm Fresh

    SuperValu (SVU) announced on March 14 that it’s selling 21 of its 38 Farm Fresh stores to three grocery store chains.

    By Sonya Bells
  • uploads///pill _
    Consumer

    Walgreens and AmerisourceBergen End Talks without a Deal

    According to a report by CNBC, talks between Walgreens Boots Alliance (WBA) and AmerisourceBergen Corp. (ABC) ended without an agreement.

    By Sonya Bells
  • uploads///
    Consumer

    How the Drug Store Industry Is Changing

    The top three drugstore chains in the US are in the process of forming new associations through mergers and acquisitions to create a more diversified portfolio and protect themselves from the growing online threat.

    By Sonya Bells
  • uploads///
    Consumer

    Analyzing the Synergies that Could Come from the Albertsons-Rite Aid Deal

    Albertsons Companies is planning to rebrand its existing pharmacies (excluding Jewel Osco) as Rite Aid stores.

    By Sonya Bells
  • uploads///
    Consumer

    Albertsons-Rite Aid Deal: What to Expect from Combined Entity

    The proposed transaction would create a company that is projected to generate $83 billion in total sales and ~$3.7 billion (including run rate cost synergies) in adjusted EBITDA during the first year.

    By Sonya Bells
  • uploads///thermometer _
    Consumer

    Albertsons Proposes Merger with Rite Aid

    On February 20, 2018, privately held Albertsons announced its intention to merge with Rite Aid (RAD), one of America’s leading drugstore chains.

    By Sonya Bells
  • uploads///hands _
    Consumer

    Privately Held Albertsons Companies to Merge with Rite Aid

    Privately held grocery chain Albertsons Companies announced its merger with drugstore chain Rite Aid (RAD) on February 20, 2018.

    By Sonya Bells
  • uploads///
    Consumer

    Would Acquiring AmerisourceBergen Make Sense for Walgreens?

    Why would Walgreens acquire AmerisourceBergen? As discussed, The Wall Street Journal recently reported that Walgreens Boots Alliance (WBA) is in acquisition talks with AmerisourceBergen (ABC). The deal, if proposed and completed, would combine America’s largest pharmacy chain (by drugstore count) with one of the largest drug distributors in the country. The significant deal would further consolidate […]

    By Sonya Bells
  • uploads///a
    Consumer

    Walgreens’s US Pharmacy Sales Strong, Retail Sales Still Soft

    Walgreens Boots Alliance’s (WBA) 1Q18 top-line growth was driven by strong performances from all three of its divisions.

    By Sonya Bells
  • uploads///
    Consumer

    Walgreens Delivers Strong Top-Line Growth in 1Q18

    As we’ve discussed, Walgreens Boots Alliance (WBA) reported its 1Q18 results on January 4. The company’s top line increased 7.9% YoY (year-over-year) to $30.74 billion.

    By Sonya Bells
  • uploads///
    Consumer

    Walgreens Beats 1Q18 Sales and Earnings Expectations

    Walgreens Boots Alliance (WBA) reported its results for 1Q18 on Thursday, January 4. The results relate to the three-month period ending November 30, 2017.

    By Sonya Bells
  • uploads///
    Consumer

    Wall Street’s Take on Rite Aid after 3Q17 Results

    Wall Street kept its stance unchanged on Rite Aid (RAD) after its third-quarter results. Evercore ISI, however, initiated coverage on the company on January 5 with an “underperform” rating.

    By Sonya Bells
  • uploads///
    Consumer

    Stock Watch: No Respite for Rite Aid’s Shareholders

    As we discussed throughout this series, Rite Aid (RAD) reported better-than-expected quarterly profits on January 3. However, the third quarter results couldn’t stop the slide in the company’s stock price.

    By Sonya Bells
  • uploads///
    Consumer

    Depressed Retail Pharmacy Gross Profit Impacts Rite Aid’s 3Q17

    Rite Aid Corporation (RAD) reported third-quarter results on January 3. The company’s adjusted net earnings from continuing operations stood at $1.6 million, or $0.00 per diluted share, compared to $26.8 million or $0.03 per diluted share during the same period last year.

    By Sonya Bells
  • uploads///
    Consumer

    Rite Aid’s 3Q17 Top Line Drivers

    As we outlined in the previous part of this series, Rite Aid (RAD) reported a 5.6% YoY (year-over-year) fall in revenue from continued operations to $5.35 billion during the third quarter of 2017.

    By Sonya Bells
  • uploads///a
    Consumer

    Rite Aid’s Top Line Plunges for the 3rd Straight Quarter in 3Q17

    Rite Aid (RAD) reported its 3Q17 results after the market closed on January 3. The company’s top line plunged 5.6% YoY (year-over-year) to $5.35 billion (excluding discontinued operations).

    By Sonya Bells
  • uploads///
    Consumer

    Rite Aid’s 3Q17 Results: A Quick Look

    Rite Aid Corporation (RAD) reported results for 3Q17 on Wednesday, January 3. The results relate to the three-month period ending December 2, 2017.

    By Sonya Bells
  • uploads///a
    Consumer

    Deal of the Year: CVS to Buy Aetna for $69 Billion

    CVS Health (CVS), America’s largest pharmacy chain, announced a $69 billion deal to purchase Aetna (AET), the country’s third-largest insurance company, on December 3, 2017.

    By Sonya Bells
  • uploads///
    Company & Industry Overviews

    Rite Aid Added Apple Pay for Online Payments

    US-based (SPY) drugstore chain Rite Aid (RAD) announced that it was adding Apple’s (AAPL) Apple Pay as a payment option for online purchases.

    By Ruchi Gupta
  • uploads///Petmed Risks
    Company & Industry Overviews

    Key Risks Facing PetMed Express in 2017

    PetMed Express (PETS) stock has risen 77% in the last one-year period, reaching a high of $50.06 on July 26, 2017.

    By Kenneth Smith
  • uploads///PetMed Revenue growth
    Company & Industry Overviews

    New Customer Acquisition Drives Revenue Growth for PetMed Express

    In 2017, the PetMed Express (PETS) website attracted ~32.0 million visitors, ~8.0% of whom placed an order for a conversion ratio of ~25.0%.

    By Kenneth Smith
  • uploads///Part
    Company & Industry Overviews

    Analysts’ Recommendations for PetMed Express and Peers in 2017

    Of the five analysts covering PetMed Express (PETS) in October 2017, two gave it “strong buy” ratings, two gave it “hold” ratings, and one gave it a “sell” rating. Its target price was $43.75.

    By Kenneth Smith
  • uploads///
    Consumer

    CVS Health May Vertically Integrate Further by Acquiring Aetna

    With trailing 12-month sales of $181 billion, CVS Health is a pharmacy colossus. However, its focus seems to be on becoming more than just a retail pharmacy chain.

    By Sonya Bells
  • uploads///
    Consumer

    Walgreens: Strong 4Q17 Results Support the Falling Stock Price

    Walgreens Boots Alliance’s strong 4Q17 results were received well by the market. The company’s stock price rose 3% and closed at $69.36 on October 25.

    By Sonya Bells
  • uploads///
    Consumer

    Can Walgreens Exceed Analyst Expectations in Fiscal 4Q17?

    Walgreens Boots Alliance (WBA) is slated to release its fiscal 4Q17 earnings on October 25. WBA’s total sales are expected to reach $29.6 billion, a 4.6% increase over its fiscal 4Q16 sales.

    By Sonya Bells
  • uploads///
    Company & Industry Overviews

    CVS versus Walgreens: Which Has a More Diversified Business Model?

    CVS generates close to 70% of its annual sales by offering a full range of pharmacy benefit management services.

    By Sonya Bells
  • uploads///
    Company & Industry Overviews

    Walgreens versus CVS: Comparing Pharmacy Giants

    The US drugstore market is dominated by two major players—CVS Health (CVS) and Walgreens Boots Alliance (WBA). CVS and WBA accounted for ~29% of the country’s prescription dispensing revenues in 2016.

    By Sonya Bells
  • uploads///Part
    Miscellaneous

    Stock Price and Valuation Trends for Food and Drug Retailers

    The stock prices of Target and CVS Health rose seven sessions in a row, from June 15–June 23. The pharmacy sale announcement by both companies resulted in a positive reception by the markets.

    By Phalguni Soni
  • uploads///
    Consumer

    Walgreens, Rite Aid, CVS Tumble on the Amazon Scare

    Three months after its Whole Foods acquisition, Amazon is making waves again with rumors that it is eying the prescription drug distribution business.

    By Sonya Bells
  • uploads///
    Consumer

    Rite Aid Stock Has Upside of 24% in the Next 12 Months

    Rite Aid’s stock crashed 11%, touching a four-year low after the company missed revenue expectations and reported weak sales comps on September 28.

    By Sonya Bells
  • uploads///
    Consumer

    One-Time Termination Fees Boost Rite Aid’s Reported Earnings

    Rite Aid (RAD) reported 2Q net earnings of $170.7 million, or 16 cents per share.

    By Sonya Bells
  • uploads///
    Consumer

    What Drove Rite Aid’s 2Q17 Revenue Decline?

    As outlined in the previous section, Rite Aid (RAD) reported a 4.4% YoY (year-over-year) decline in total sales to $7.7 billion during 2Q17.

    By Sonya Bells
  • uploads///
    Consumer

    How Walgreens and Rite Aid Can Benefit from their Deal

    As we’ve discussed in this series, Walgreens received FTC (Federal Trade Commission) approval to acquire 1,932 Rite Aid store on September 19.

    By Sonya Bells
  • uploads///
    Consumer

    Rite Aid Loses 12% after the FTC Nod for Walgreens Deal

    The stock price for Rite Aid (RAD) plunged more than 12% after the announcement of the deal closure with Walgreens on September 19.

    By Sonya Bells
  • uploads///
    Consumer

    A Look at Rite Aid’s Stock Crash This Year

    Rite Aid’s shareholders have been the real losers from the delay and eventual termination of the deal between Rite Aid (RAD) and Walgreens Boots Alliance (WBA) in October 2015.

    By Sonya Bells
  • uploads///
    Consumer

    Status Update: The Walgreens–Rite Aid Acquisition Deal

    According to Bloomberg, Walgreens Boots Alliance (WBA) and Rite Aid (RAD) have moved toward closing their long-awaited acquisition deal.

    By Sonya Bells
  • uploads///
    Consumer

    Here’s Why Rite Aid’s Margins Have Deteriorated over the Years

    Rite Aid’s profitability has worsened over the years. Its gross margin has fallen from 29.0% in fiscal 2013 to just 22.6% in the first quarter of the current fiscal year.

    By Sonya Bells
  • uploads///
    Consumer

    Rite Aid Ready to Report 2Q17 Earnings: What to Expect

    Rite Aid (RAD) is slated to release its fiscal 2Q17 results on Thursday, September 28, 2017. Its EPS (earnings per share) is projected to fall to zero from last year’s $0.01.

    By Sonya Bells
  • uploads///
    Fund Managers

    Behind Einhorn’s Top Sells in 1Q17

    As of March 31, 2017, the top selling in billionaire investor David Einhorn’s portfolio included Apple, Time Warner, Rite Aid, and AerCap Holdings.

    By Sarah Sands
  • uploads///
    Miscellaneous

    The WBA-RAD Deal Drama Has Hurt Both Companies’ Stocks

    On June 29, 2017, Walgreens Boots Alliance (WBA) and Rite Aid (RAD) announced that they have a new definitive agreement.

    By Sonya Bells
  • uploads///
    Miscellaneous

    Rite Aid, Fred’s, and Walgreens Rose Due to Possible Deal Closure

    Rite Aid, Fred’s, and Walgreens Boots Alliance’s stock prices rose on June 26. The Rite Aid-Walgreens merger might be getting close to a conclusion.

    By Sonya Bells
  • uploads///
    Miscellaneous

    Wall Street Sees a 22% Upside in Walgreens

    Walgreens is covered by 25 Wall Street analysts. The company has received a rating of 2 on a scale of 1 (strong buy) to 5 (sell). It has 72% “buy” and 28% “hold” recommendations and no “sell” recommendations.

    By Sonya Bells
  • uploads///Picture
    Miscellaneous

    The FTC Might Be Looking to Block the WBA-RAD Merger

    According to a recent report from The Capital Forum, the FTC is set to block the pending merger of Walgreens Boots Alliance (WBA) and Rite Aid (RAD).

    By Sonya Bells
  • uploads///
    Miscellaneous

    Walgreens on the Street: What the Analysts Say after Fiscal 2Q17

    Wall Street’s reaction to WBA’s second quarter results While Walgreens (WBA) delivered mixed 2Q17 results, CEO (chief executive officer) Stefano Pessina’s optimism about the pending Rite Aid (RAD) deal has been well received by the analyst community. John Heinbockel of Guggenheim maintained a “buy” rating on WBA, issuing a price target of $100. While Heinbockel […]

    By Sonya Bells
  • uploads///
    Earnings Report

    Walgreens, Rite Aid, and Fred’s: The Shifting Landscape

    WBA’s CEO, Stefano Pessina, said that he remains positive about the Rite Aid deal, which has been waiting for FTC approval for more than a year.

    By Sonya Bells
  • uploads///
    Earnings Report

    Walgreens’ Fiscal 2Q17 Earnings Overview: Revenue Miss, In-Line EPS

    WBA’s fiscal 2Q17 EPS stood at $1.36, in line with estimates. Its top line, however, missed the consensus estimate, falling 2.4% YoY to ~$29.5 billion.

    By Sonya Bells
  • uploads///
    Earnings Report

    Wall Street Optimistic on Walgreens ahead of Fiscal 2Q17 Results

    Walgreens Boots Alliance (WBA) is currently trading at $83.56 as of March 27, 2017, which is ~5.3% below its 52-week high.

    By Sonya Bells
  • uploads///a
    Miscellaneous

    Rite Aid Shares Could Slide 53% if WBA-RAD Falls Apart

    In a recent research note, a Deutsche Bank analyst warned about a sharp plunge in Rite Aid’s share price if its proposed deal with Walgreens Boots Alliance falls apart.

    By Sonya Bells
  • uploads///
    Miscellaneous

    The WBA-RAD Merger and the 43% Fall in Rite Aid Stock

    Uncertainty over closing the proposed merger between Walgreens Boots Alliance (WBA) and Rite Aid (RAD) has resulted in a 42.8% fall in RAD stock YTD.

    By Sonya Bells
  • uploads///
    Miscellaneous

    What’s Happened since the Walgreens–Rite Aid October 2015 Deal?

    The merger of Walgreens and Rite Aid would join the second- and third-largest drugstore chains and thus significantly reduce competition.

    By Sonya Bells
  • uploads///
    Miscellaneous

    Walgreens–Rite Aid Merger Deal: The Drama and the Wait

    According to a recent Bloomberg report, Walgreens is working on preparing a new deal with Rite Aid in order to please regulatory authorities.

    By Sonya Bells
  • uploads///
    Miscellaneous

    Who Loses with the Walgreens–Rite Aid Amended Merger Agreement?

    Walgreens Boots Alliance (WBA) and Rite Aid (RAD) have amended their merger agreement. WBA will now pay less for each RAD share, depending on the number of locations it must divest.

    By Sonya Bells
  • uploads///
    Miscellaneous

    Rite Aid Stock Tanks as Walgreens Drops Merger Price

    Walgreens Boots Alliance (WBA) and Rite Aid (RAD) have amended their merger agreement. Walgreens will now pay $6.50–$7 per share instead of $9.

    By Sonya Bells
  • uploads///
    Earnings Report

    After Walgreens’s 1Q17 Results, Wall Street Remains Positive

    Analysts have a positive to neutral view on Walgreens and has rated its stock a “2” on a scale of “1-strong buy” to “5-sell.”

    By Sonya Bells
  • uploads///
    Earnings Report

    Strong Performance for Walgreens’s Retail Pharmacy USA Division

    In fiscal 1Q17, sales for WBA’s Retail Pharmacy USA division rose 1.4%. It was the only segment that reported sales growth.

    By Sonya Bells
  • uploads///
    Earnings Report

    Walgreens’s Currency Headwinds for Its International Businesses

    In the last couple of quarters, Walgreens Boots Alliance’s (WBA) fiscal 1Q17 top line was negatively affected by currency headwinds, falling 1.8% YoY.

    By Sonya Bells
  • uploads///
    Earnings Report

    Walgreens Reported Top-Line Fall for First Time in 4 Years

    In fiscal 1Q17, WBA reported a top-line fall for the first time in the last 16 quarters. But the fall in revenues was primarily due to currency headwinds.

    By Sonya Bells
  • uploads///gnc pm
    Company & Industry Overviews

    GNC Holdings Announces the Implementation of New Plans

    GNC Holdings reported 3Q16 revenues of $628.0 million, a fall of 8.1% compared to revenues of $683.4 million in 3Q15.

    By Gabriel Kane
  • uploads///
    Earnings Report

    Walgreens Boots Alliance’s SWOT Analysis ahead of 1Q17 Results

    Let’s wrap up this series on Walgreens (WBA) with a brief SWOT (strengths, weaknesses, opportunities, and threats) to gauge the company’s standing.

    By Sonya Bells
  • uploads///
    Earnings Report

    Walgreens Stock Has a Potential Upside of 8.0% over the Next Year

    Walgreens Boots Alliance (WBA) is currently trading at $86.08 as of December 19, 2016, which is ~2.2% below its 52-week high. The stock has risen 1.0% YTD.

    By Sonya Bells
  • uploads///
    Earnings Report

    A Look at Walgreens Boots Alliance’s Initiatives and Partnerships

    During fiscal 2016, Walgreens entered into various strategic partnerships to advance its retail and pharmacy operations.

    By Sonya Bells
  • uploads///
    Earnings Report

    A Sneak Peek at Walgreens’ Fiscal 2016 Top-Line Performance

    Walgreens Boots Alliance (WBA) posted strong results in fiscal 2016. Revenues rose 13.4% YoY, and EPS rose 18.3% over the previous year.

    By Sonya Bells
  • uploads///
    Miscellaneous

    Will the WBA-RAD Deal Clear FTC Hurdles?

    Walgreens Boots Alliance (WBA) is looking to divest 650 stores in order to win the Federal Trade Commission’s (FTC) approval for its pending Rite Aid (RAD) acquisition.

    By Sonya Bells
  • uploads///
    Miscellaneous

    Where Does Walgreens’s Deal with Rite Aid Stand a Year Later?

    Walgreens’s deal with Rite Aid is currently awaiting the Federal Trade Commission’s (or FTC) approval. The FTC has asked Walgreens to close or sell ~650 stores.

    By Sonya Bells
  • uploads///gnc ps
    Earnings Report

    How Does GNC Holdings Compare to Its Peers?

    GNC’s peers have outperformed GNC Holdings based on PE and PBV ratios. But GNC has mostly outperformed its peers based on PS ratios.

    By Gabriel Kane
  • uploads///gnc pm
    Earnings Report

    GNC Holdings’ 3Q16 Revenue Fell 8.1%: What Does It Mean?

    GNC Holdings (GNC) reported 3Q16 revenue of $628.0 million, a fall of 8.1%. Its gross profit margin and operating margin fell 240 bps and 170 bps, respectively.

    By Gabriel Kane
  • uploads///a
    Earnings Report

    Is CVS a Better Buy than WBA? Here’s Wall Street’s View

    Walgreens Boots Alliance and CVS Health are both covered by 26 Wall Street analysts each.

    By Sonya Bells
  • uploads///
    Earnings Report

    Walgreens’s Deal with Rite Aid Still on, but Delayed

    In October 2015, Walgreens Boots Alliance (WBA) announced its intention to acquire Rite Aid (RAD) for a total enterprise value of $17.2 billion.

    By Sonya Bells
  • uploads///
    Earnings Report

    In Walgreens-Rite Aid Deal, $1 Billion in Synergies on the Table

    WBA is still awaiting approval from the FTC, which has asked WBA to shut or sell around 650 of its stores, or ~5% of the WBA-RAD combined store count.

    By Sonya Bells
  • uploads///gnc pm
    Consumer

    Analyzing GNC Holdings’ Performance in 2Q16

    GNC Holdings has a market cap of $1.5 billion. It fell by 25.5% and closed at $20.28 per share on July 28, 2016. It reported 2Q16 revenue of $673.2 million.

    By Gabriel Kane
  • uploads///
    Consumer

    How Was Walgreens’s Retail Pharmacy Business Performance in the US?

    Walgreens (WBA) operates close to 8,200 pharmacies in the US. It is closely followed by CVS Health (CVS), which operates slightly fewer than 8,000 pharmacies.

    By Sonya Bells
  • uploads///Total IG Bond Issuance in Week Ending May
    Company & Industry Overviews

    Walgreens Boots Alliance Issued the Most High-Grade Bonds

    Walgreens Boots Alliance (WBA) issued Baa2/BBB rated high-grade bonds worth $6.0 billion through five parts on May 26.

    By Lynn Noah
  • uploads///Part
    Company & Industry Overviews

    Why Target Is Focusing on Its Signature Categories to Drive Sales

    Target has identified four signature categories it’s concentrating on to provide higher store and web traffic and sales: Baby, Style, Wellness, and Kids.

    By Phalguni Soni
  • uploads///
    Earnings Report

    What Were the Key Revenue Drivers for WBA in 1Q16?

    Walgreens Boots Alliance’s (WBA) sales rose 48.5% YoY (year-over-year) to $29 billion in 1Q16. The increase was largely driven by the consolidation of Alliance Boots’ operations.

    By Sonya Bells
  • uploads///
    Earnings Report

    How Does WBA’s Stock Market Performance Compare to Peers?

    After delivering a decent performance in the stock market in 2015 with returns of 12%, Walgreens Boots Alliance (WBA) had a rought start in 2016.

    By Sonya Bells
  • uploads///sp
    Company & Industry Overviews

    Who Were the Outliers in the Consumer Space?

    The S&P 500 slightly outperformed the S&P Consumer Staples and the S&P Consumer Discretionary last week.

    By Gabriel Kane
    • CONNECT with Market Realist
    • Link to Facebook
    • Link to Twitter
    • Link to Instagram
    • Link to Email Subscribe
    Market Realist Logo
    Do Not Sell My Personal Information

    © Copyright 2021 Market Realist. Market Realist is a registered trademark. All Rights Reserved. People may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.